Cyclomedica News

Technegas™ approved in Russia

26th May 2020

Continue Reading

Clinical research opportunity in COVID-19

4th May 2020

Continue Reading

Register your interest to be the first to get Technegas™ in the USA

24th Apr 2020

Continue Reading

Cyclomedica Lodges NDA for Technegas® with the USFDA

30th Mar 2020

Continue Reading

Technegas™ is not an aerosol generating procedure

24th Mar 2020

Continue Reading

Technegas™ and Covid-19

24th Mar 2020

Continue Reading

Visit us at booth #878 – SNMMI 2019 Annual Meeting

15th Apr 2019

Continue Reading

Cyclomedica will exhibit at the EANM 2019 congress

19th Mar 2019

Continue Reading

Cyclomedica will exhibit at the German Annual Meeting of Nuclear Medicine

19th Mar 2019

Continue Reading

Cyclopharm (ASX:CYC) results of US FDA meeting

19th Mar 2019

Continue Reading

New Guidelines from the Canadian Association of Nuclear Medicine

11th Oct 2018

Continue Reading

Cyclopharm (ASX:CYC) radiopharmaceutical leader

9th Oct 2018

Continue Reading

Our 4th million Patient Administration Set has been manufactured

31st May 2018

Continue Reading

New clinical trial to develop better tools for asthma and COPD

18th May 2018

Continue Reading

First 40 patients’ milestone reached in USFDA Phase 3 Technegas study

29th Mar 2018

Continue Reading

Copyright © Cyclomedica Canada 2020 | Last Updated: March 8, 2019 Privacy Policy